✦ LIBER ✦

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study

✍ Scribed by Emanuel Zitt; Christine Jäger; Alexander R. Rosenkranz; Manfred Eigner; Katharina Kodras; Josef Kovarik; Helmut Graf; Frank Pétavy; Sabine Horn; Bruno Watschinger

Publisher: Springer Vienna
Year: 2011
Tongue: English
Weight: 258 KB
Volume: 123
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-010-1515-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistent Dyslipidemia in Austrian pati

Persistent Dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events – Results of the dyslipidemia international study (DYSIS)

✍ Heinz Drexel; Francois Chazelle; Christiane Fauer; Dominik Lautsch; Anselm K Git 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 367 KB

Surgical and medical management of patie

Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study

✍ M. Jauss; D. Krieger; C. Hornig; J. Schramm; O. Busse; for the GASCIS study cent 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 100 KB

The treatment of seasonality in error co

The treatment of seasonality in error correction models as unobserved component: a case study for an Austrian consumption function

✍ Michael Wüger; Gerhard Thury 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 325 KB

The potential risk of neoadjuvant chemot

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

✍ Susanne Taucher; Guenther G. Steger; Raimund Jakesz; Christoph Tausch; Viktor We 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 252 KB

Plasma drug and antiplatelet profiles of

Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction

✍ R. Simrock; K. Rehders; H. Spahn; E. Mutschler; H. K. Breddin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 926 KB

Disparities in the use of immunomodulato

Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: A retrospective cohort study

✍ Mark H. Flasar; Tamara Johnson; Mary-Claire Roghmann; Raymond K. Cross 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Treatment disparities between african americans (aa) and caucasians exist in multiple diseases. there are limited studies in inflammatory bowel disease (ibd). our objectives were to assess differences in ibd therapies between aa and caucasians, controlling for disease severity. ## M